Protocatechualdehyde ameliorates OGD/R-induced endothelial injury via the ROS/miR-29b-3p/SIRT1 regulatory axis
Frontiers in Pharmacology · 12.08.2026 · 17
DOI: 10.3389/fphar.2026.1904530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 12.08.2026. Verfasst von Yanqing Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, China. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
MicroRNA-29b-3p (miR-29b-3p) plays a critical role in regulating endothelial apoptosis and autophagy. We previously demonstrated that protocatechualdehyde (PCA), a water-soluble phenolic acid derived from Salvia miltiorrhiza Bge., protects human umbilical vein endothelial cells (HUVECs) against oxygen-glucose deprivation/reoxygenation (OGD/R)-induced injury. However, whether miR-29b-3p mediates this protective effect remains unclear.
Methods
Using the OGD/R in vitro model of ischemia-reperfusion injury, we investigated the molecular mechanisms underlying ischemic damage at the cellular level. RT-qPCR was used to measure miR-29b-3p expression, Western blotting to assess autophagy- and apoptosis-related proteins, and MDC staining and flow cytometry to evaluate autophagy and apoptosis, respectively.
Results
The results showed that miR-29b-3p was downregulated in OGD/R-treated HUVECs, an effect that was reversed by PCA and the ROS inhibitor N-acetylcysteine (NAC). The miR-29b-3p mimic enhanced the promoting effects of PCA and NAC on miR-29b-3p expression, whereas miR-29b-3p inhibitor reversed these effects. Similarly, PCA-induced autophagy and inhibition of apoptosis were enhanced by the miR-29b-3p mimic and reversed by the inhibitor. To determine whether SIRT1 acts downstream of miR-29b-3p, we used EX527 (a SIRT1 inhibitor) and found that it attenuated the PCA-mediated upregulation of miR-29b-3p. The miR-29b-3p mimic enhanced PCA-induced SIRT1 activity and protein expression, while the inhibitor had the opposite effect. Additional experiments revealed that NAC suppressed ROS by upregulating miR-29b-3p, leading to increased SIRT1 expression and reduced apoptosis. Disscussion Collectively, these findings demonstrate that PCA ameliorates OGD/R-induced endothelial injury by promoting autophagy and inhibiting apoptosis via the ROS/miR-29b-3p/SIRT1 regulatory axis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
- School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, China.
Zitieren
APA
Wu, Y., Qiao, X., Chen, S., Lu, Y., Mao, B., Zhu, M., Chen, X., Chen, N., Ding, Z., & Jin, B. (2026). Protocatechualdehyde ameliorates OGD/R-induced endothelial injury via the ROS/miR-29b-3p/SIRT1 regulatory axis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1904530
Vancouver
Wu Y, Qiao X, Chen S, Lu Y, Mao B, Zhu M, et al. Protocatechualdehyde ameliorates OGD/R-induced endothelial injury via the ROS/miR-29b-3p/SIRT1 regulatory axis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1904530
BibTeX
@article{Wu2026,
author = {Wu, Yanqing and Qiao, Xilin and Chen, Shuaiyu and Lu, Yalan and Mao, Bingyan and Zhu, Mengdie and Chen, Xinzhi and Chen, Nipi and Ding, Zhishan and Jin, Bo},
title = {Protocatechualdehyde ameliorates OGD/R-induced endothelial injury via the ROS/miR-29b-3p/SIRT1 regulatory axis},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1904530}
}
EUVIMED